The purpose of this study was to assess the anti‐tumor effects of zaltoprofen via regulation of MMP2 and PPARγ activity, and examine whether zaltoprofen could be a novel therapeutic agent in human chondrosarcoma. The gene discussed is MMP2; the disease is chondrosarcoma.